#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small for dates baby Scedosporium infection Guillain-Barre syndrome Carcinoid tumour Splenic marginal zone lymphoma Cerebellar ataxia Metastatic malignant melanoma Antiphospholipid antibodies Ovarian cancer stage IV Primary amyloidosis Squamous cell carcinoma of the vulva Spinal cord injury cervical Precursor T-lymphoblastic lymphoma/leukaemia recurrent Malignant central nervous system neoplasm Langerhans cell sarcoma More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Treatment Breast angiosarcoma – Life with Disease Synovial sarcoma – Diagnostics Mantle cell lymphoma stage III – Diagnostics Hereditary hypophosphataemic rickets Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Rett syndrome Mucopolysaccharidosis – Trials in Disease Burkitt’s lymphoma – Trials in Disease Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Df6002 Iph5201 Emtricitabine Anakinra Vismodegib Stiripentol Trazodone L-ALANINE Specific Nucleic Acid Sna-Papi Amoxicillin Sodium Anifrolumab Metoclopramide Hydrochloride RO7795081 Spartalizumab Antiemetics And Antinauseants Ranibizumab Betula Verrucosa (108) Gs-5718-03 Alrefimotide Midomafetamine Hydrochloride More therapies…

    Learn about Your Condition

    Endometrial cancer stage IV Endotracheal intubation Hypereosinophilic syndrome Neonatal hyperglycaemia Hyperhidrosis Coagulopathy Thalassaemia Rubella Dystonia Bone marrow failure Non-Hodgkin's lymphoma Lung neoplasm malignant Encephalitis Japanese B Paedophilia Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Difelikefalin for Adults with Moderate-to-Severe Itching from Notalgia Paresthetica

    Not recruiting

    4 1
    Investigated Drugs:
    • Difelikefalin
    Germany Poland Spain

  • Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Lichen sclerosus
    Investigated Drugs:
    • Alanyl Glutamine
    Denmark

  • Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
    Czechia France Germany Hungary Poland Romania +1

  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Lebrikizumab
    Germany The Netherlands

  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    • Deucravacitinib
    Hungary Poland Romania Spain

  • Study on the Safety and Effectiveness of SXR1096 Cream for Patients with Netherton Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Netherton’s syndrome
    Investigated Drugs:
    • Sxr1096
    Austria France Germany Sweden
Previous Page
1 … 53 54 55 56 57 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!